Search

Kirby, Joslyn S, Martin M Okun, Afsaneh Alavi, Falk G Bechara, Christos C Zouboulis, Kurt Brown, Leandro L Santos, et al. 2024. “Efficacy and Safety of the Oral Janus Kinase 1 Inhibitor Povorcitinib (INCB054707) in Patients With Hidradenitis Suppurativa in a Phase 2, Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study.”. Journal of the American Academy of Dermatology 90 (3): 521-29.

Kimball, Alexa B, Gregor B E Jemec, Afsaneh Alavi, Ziad Reguiai, Alice B Gottlieb, Falk G Bechara, Carle Paul, et al. 2023. “Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa (SUNSHINE and SUNRISE): Week 16 and Week 52 Results of Two Identical, Multicentre, Randomised, Placebo-Controlled, Double-Blind Phase 3 Trials.”. Lancet (London, England) 401 (10378): 747-61.

Porter, Martina L, Prerna Salian, Monica Rosales Santillan, Charlotte Greif, and Alexa B Kimball. 2022. “An Open-Label, Prospective, Pilot Study of Hypertonic Saline for Hidradenitis Suppurativa.”. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 48 (9): 954-60.

Golbari, Nicole Mona, Martina Lee Porter, and Alexa Boer Kimball. 2018. “Response To: Remission of Hidradenitis Suppurativa After Bariatric Surgery.”. JAAD Case Reports 4 (3): 278-79.

Egeberg, Alexander, Gregor B E Jemec, Alexa B Kimball, Hervé Bachelez, Gunnar H Gislason, Jacob P Thyssen, and Lotus Mallbris. 2017. “Prevalence and Risk of Inflammatory Bowel Disease in Patients With Hidradenitis Suppurativa.”. The Journal of Investigative Dermatology 137 (5): 1060-64.

Porter, Martina L, and Alexa B Kimball. 2017. “Hidradenitis Suppurativa Scoring Systems: Can We Choose just One?”. Cutis 99 (3): 156-57.

Kimball, Alexa B, Martin M Okun, David A Williams, Alice B Gottlieb, Kim A Papp, Christos C Zouboulis, April W Armstrong, et al. 2016. “Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.”. The New England Journal of Medicine 375 (5): 422-34.

Jemec, Gregor B E, and Alexa B Kimball. 2015. “Hidradenitis Suppurativa: Epidemiology and Scope of the Problem.”. Journal of the American Academy of Dermatology 73 (5 Suppl 1): S4-7.

Kohorst, John J, Alexa B Kimball, and Mark D P Davis. 2015. “Systemic Associations of Hidradenitis Suppurativa.”. Journal of the American Academy of Dermatology 73 (5 Suppl 1): S27-35.

Crowley, J J, J R Mekkes, C C Zouboulis, N Scheinfeld, A Kimball, M Sundaram, Y Gu, M M Okun, and F Kerdel. 2014. “Association of Hidradenitis Suppurativa Disease Severity With Increased Risk for Systemic Comorbidities.”. The British Journal of Dermatology 171 (6): 1561-5.